CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2025

Aug 8, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-08-01

Reporting Person: Curran Daniel J. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase common stock	$21.12	2032-08-01	Common Stock (40000)		Direct

Footnotes

F1: Options vest in three annual tranches beginning on August 1, 2026.